[HTML][HTML] The biological pathways of Alzheimer disease: A review

M Calabrò, C Rinaldi, G Santoro, C Crisafulli - AIMS neuroscience, 2021 - ncbi.nlm.nih.gov
Alzheimer disease is a progressive neurodegenerative disorder, mainly affecting older
people, which severely impairs patients' quality of life. In the recent years, the number of …

Cerebrovascular disease in ageing and Alzheimer's disease

S Love, JS Miners - Acta neuropathologica, 2016 - Springer
Cerebrovascular disease (CVD) and Alzheimer's disease (AD) have more in common than
their association with ageing. They share risk factors and overlap neuropathologically. Most …

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease

CE Evans, JS Miners, G Piva, CL Willis, DM Heard… - Acta …, 2020 - Springer
Mid-life hypertension and cerebrovascular dysfunction are associated with increased risk of
later life dementia, including Alzheimer's disease (AD). The classical renin–angiotensin …

Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology

PG Kehoe, S Wong, N Al Mulhim, LE Palmer… - Alzheimer's research & …, 2016 - Springer
Background Hyperactivity of the classical axis of the renin-angiotensin system (RAS),
mediated by angiotensin II (Ang II) activation of the angiotensin II type 1 receptor (AT1R), is …

Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions

S Andrieu, N Coley, S Lovestone, PS Aisen… - The Lancet …, 2015 - thelancet.com
Interventions that have even quite modest effects at the individual level could drastically
reduce the future burden of dementia associated with Alzheimer's disease at the population …

The coming of age of the angiotensin hypothesis in Alzheimer's disease: progress toward disease prevention and treatment?

PG Kehoe - Journal of Alzheimer's Disease, 2018 - content.iospress.com
There is wide recognition of a complex association between midlife hypertension and
cardiovascular disease and later development of Alzheimer's disease (AD) and cognitive …

Contributions by the brain renin-angiotensin system to memory, cognition, and Alzheimer's disease

JW Wright, JW Harding - Journal of Alzheimer's Disease, 2019 - content.iospress.com
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive
neuron losses in memory-associated brain structures that rob patients of their dignity and …

Stimulation of ACE2/ANG(1–7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway

AS Kamel, NF Abdelkader, SS Abd El-Rahman… - Molecular …, 2018 - Springer
Overactivation of angiotensin-converting enzyme/angiotensin 2/angiotensin receptor-1
(ACE/Ang2/AT1) axis provokes amyloid-β-induced apoptosis and neurodegeneration in …

Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies

PJ Tully, O Hanon, S Cosh, C Tzourio - Journal of Hypertension, 2016 - journals.lww.com
Objective: Diuretic drugs have been a mainstay of hypertension treatment in the elderly
however their dementia sparing effects are under-reported. The objective was to quantify …

[HTML][HTML] Vascular pathology: cause or effect in Alzheimer disease?

S Rius-Pérez, AM Tormos, S Pérez… - Neurología (English …, 2018 - Elsevier
Introduction Alzheimer disease (AD) is the main cortical neurodegenerative disease. The
incidence of this disease increases with age, causing significant medical, social and …